Medpace Holdings, Inc.
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and develā¦ read more
Healthcare
Diagnostics & Research
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$478.54
Price+1.69%
$7.95
1Y
Price
Market Cap
$13.582b
Large
Price/Earnings 3y Avg5y Avg
31.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+23.1%
EBITDA Margin+19.1%
Net Profit Margin+26.6%
Free Cash Flow Margin+23.1%
EBITDA Margin+19.1%
Net Profit Margin+26.6%
Free Cash Flow MarginRevenue
$2.530b
+20.0%
1y CAGR+20.3%
3y CAGR+22.2%
5y CAGREarnings
$451.123m
+11.6%
1y CAGR+23.3%
3y CAGR+26.2%
5y CAGREPS
$15.28
+21.2%
1y CAGR+28.5%
3y CAGR+34.2%
5y CAGRBook Value
$459.071m
$1.975b
Assets$1.516b
Liabilities$250.495m
DebtDebt to Assets
12.7%
0.4x
Debt to EBITDAFree Cash Flow
$681.867m
+23.8%
1y CAGR+27.0%
3y CAGR+32.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company